These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26384280)

  • 41. Langerhans Cell Histiocytosis of the Orbit: Spectrum of Disease and Risk of Central Nervous System Sequelae in Unifocal Cases.
    Esmaili N; Harris GJ
    Ophthalmic Plast Reconstr Surg; 2016; 32(1):28-34. PubMed ID: 25689784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis.
    Pardanani A; Phyliky RL; Li CY; Tefferi A
    Mayo Clin Proc; 2003 Mar; 78(3):301-6. PubMed ID: 12630583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy and safety of intermediate-dose cytarabine in the treatment of children with refractory high risk Langerhans cell histiocytosis].
    Wang WQ; Ge J; Ma HH; Lian HY; Cui L; Zhang L; Li ZG; Wang TY; Zhang R
    Zhonghua Er Ke Za Zhi; 2023 Dec; 61(12):1118-1123. PubMed ID: 38018049
    [No Abstract]   [Full Text] [Related]  

  • 44. Successful treatment of multiple relapsed-refractory Langerhans cell histiocytosis with cyclosporine.
    Özyörük D; Yozgat AK; Kaçar D; Yazal Erdem A; Işık M; Güzelküçük Z; Hacısalihoğlu Ş
    Tumori; 2021 Dec; 107(6):NP120-NP122. PubMed ID: 34423687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolated tumorous Langerhans cell histiocytosis of the brainstem: a diagnostic and therapeutic challenge.
    Savardekar A; Tripathi M; Bansal D; Vaiphei K; Gupta SK
    J Neurosurg Pediatr; 2013 Sep; 12(3):258-61. PubMed ID: 23848290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Recurrent and Refractory Langerhans Cell Histiocytosis in Children Treated with the Combination of Cladribine and Cytarabine].
    DU Y; Xiong H; Li H; Li JX; Tao F; Yang L; Lu WJ; Qi SS; Zhang LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):943-949. PubMed ID: 35680831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cladribine activity in adult langerhans-cell histiocytosis.
    Saven A; Burian C
    Blood; 1999 Jun; 93(12):4125-30. PubMed ID: 10361109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of refractory Langerhans cell histiocytosis (LCH) with a combination of 2-chlorodeoxyadenosine and cytosine arabinoside.
    Apollonsky N; Lipton JM
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):53-6. PubMed ID: 19125089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis.
    Grobost V; Khouatra C; Lazor R; Cordier JF; Cottin V
    Orphanet J Rare Dis; 2014 Nov; 9():191. PubMed ID: 25433492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral Langerhans Cell Histiocytosis in an Infant.
    Halperson E; Weintraub M
    J Dent Child (Chic); 2018 May; 85(2):75-78. PubMed ID: 30345957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine.
    Rodriguez-Galindo C; Kelly P; Jeng M; Presbury GG; Rieman M; Wang W
    Am J Hematol; 2002 Mar; 69(3):179-84. PubMed ID: 11891804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Adult Langerhans cell histiocytosis treated by cladribine: a case report].
    Wang XP; Wu T; Guo M; Xi R; Pan YZ; Wang CB; Bai H
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):611. PubMed ID: 32397029
    [No Abstract]   [Full Text] [Related]  

  • 53. Adult vulvar Langerhans cell histiocytosis: a rare presentation.
    Sousa C; Lopes J; Teixeira D; Furtado A; Coelho H; Baptista A; Rocha N
    Int J Dermatol; 2020 Feb; 59(2):e40-e41. PubMed ID: 31605379
    [No Abstract]   [Full Text] [Related]  

  • 54. A case of Langerhans'-cell histiocytosis with membranous nephropathy.
    Rachima CM; Cohen E; Iaina NL; Tobar A; Garty M
    Am J Kidney Dis; 2004 Feb; 43(2):e3-9. PubMed ID: 14750117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recognition and treatment of concurrent active and neurodegenerative langerhans cell histiocytosis: a case report.
    Ehrhardt MJ; Karst J; Donohoue PA; Maheshwari M; McClain KL; Bingen K; Kelly ME
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e37-40. PubMed ID: 24322503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine].
    Vanícek J; Adam Z; Balsíková K; Krejcí M; Pour L; Szturz P; Zahradová L; Hájek R; Koukalová R; Rehák Z; Král Z; Mayer J
    Vnitr Lek; 2011 Oct; 57(10):871-5. PubMed ID: 22097697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. VCR/AraC chemotherapy and ND-CNS-LCH.
    Imashuku S; Shioda Y; Tsunematsu Y; Imamura T; Morimoto A;
    Pediatr Blood Cancer; 2010 Jul; 55(1):215-6. PubMed ID: 20310001
    [No Abstract]   [Full Text] [Related]  

  • 58. Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
    Morimoto A; Shioda Y; Imamura T; Kudo K; Kawaguchi H; Sakashita K; Yasui M; Koga Y; Kobayashi R; Ishii E; Fujimoto J; Horibe K; Bessho F; Tsunematsu Y; Imashuku S
    Int J Hematol; 2016 Jul; 104(1):99-109. PubMed ID: 27040279
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine.
    Goh NS; McDonald CE; MacGregor DP; Pretto JJ; Brodie GN
    Respirology; 2003 Mar; 8(1):91-4. PubMed ID: 12856748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Langerhans cell histiocytosis and acute leukemia: unusual association in two cases.
    Aricò M; Comelli A; Bossi G; Raiteri E; Piombo M; Egeler RM
    Med Pediatr Oncol; 1993; 21(4):271-3. PubMed ID: 8469222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.